Clinical Trial Update: Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial update on oral Prurisol for active moderate to severe chronic plaque psoriasis reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Prurisol

Snippet

Sponsor: Innovation Pharmaceuticals, Inc. | Conditions: Chronic Stable Plaque Psoriasis | Phase 2 | Status: COMPLETED